Dolby Laboratories (DLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 03-2020 | 12-2019 | 09-2019 | 06-2019 | 03-2019 | |
| Sales | 351,815 | 291,877 | 298,827 | 302,159 | 338,258 |
| Cost of Goods | 36,830 | 37,315 | 45,960 | 39,690 | 36,575 |
| Gross Profit | 314,985 | 254,562 | 252,867 | 262,469 | 301,683 |
| Operating Expenses | 209,870 | 206,287 | 202,607 | 228,903 | 199,328 |
| Operating Income | 105,945 | 48,590 | 51,220 | 34,256 | 102,930 |
| Interest Expense | 25 | 72 | 64 | 29 | 32 |
| Other Income | 4,859 | 5,936 | 5,095 | 7,573 | 7,104 |
| Pre-tax Income | 110,779 | 54,454 | 56,251 | 41,800 | 110,002 |
| Income Tax | 22,105 | 5,863 | 12,316 | 2,163 | 36,427 |
| Net Income Continuous | 88,674 | 48,591 | 43,935 | 39,637 | 73,575 |
| Minority Interests | 178 | -162 | 17 | 63 | 135 |
| Net Income | $88,496 | $48,753 | $43,918 | $39,574 | $73,440 |
| EPS Basic Total Ops | 0.88 | 0.49 | 0.44 | 0.39 | 0.72 |
| EPS Basic Continuous Ops | 0.88 | 0.48 | 0.44 | 0.39 | 0.72 |
| EPS Diluted Total Ops | 0.86 | 0.47 | 0.43 | 0.38 | 0.70 |
| EPS Diluted Continuous Ops | 0.86 | 0.47 | 0.43 | 0.38 | 0.70 |
| EBITDA(a) | $126,092 | $68,989 | $73,568 | $56,252 | $123,729 |